COMFORT II Study Shows Ruxolitinib as a Very Durable Treatment for MPN - 101931

Spotlight
Video

COMFORT II Study Shows Ruxolitinib as a Very Durable Treatment for MPN

ASHReport has 256 videos Subscribe Here

Loading........
Description: Aaron Gerds, MD Taussig Cancer Institute, Department of Hematology & Medical Oncology Cleveland Clinic discusses how the COMFORT II Study Shows Ruxolitinib as a Very Durable Treatment for MPN from ASH 2015
Shared By : ASHReport
Posted on : 12/10/15
Added : 3 years ago